Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients With Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.